Citation: D. Yuan et al., Pharmacological properties of traditional medicines. XXV. Effects of ephedrine, amygdalin, glycyrrhizin, gypsum and their combinations on body temperature and body fluid, BIOL PHAR B, 22(2), 1999, pp. 165-171
Citation: R. Lehner et al., Subcellullar localization, developmental expression and characterization of a liver triacylglycerol hydrolase, BIOCHEM J, 338, 1999, pp. 761-768
Authors:
Tessitore, L
Dianzani, I
Cui, Z
Vance, DE
Citation: L. Tessitore et al., Diminished expression of phosphatidylethanolamine N-methyltransferase 2 during hepatocarcinogenesis, BIOCHEM J, 337, 1999, pp. 23-27
Citation: Z. Cui et P. Prewett, Comparative study of AZPF514 and UVIII chemically amplified resists for electron beam nanolithography, MICROEL ENG, 46(1-4), 1999, pp. 255-258
Authors:
Rosenbusch, A
Cui, Z
DiFabrizio, E
Gentili, M
Glezos, N
Meneghini, G
Nowotny, B
Patsis, G
Prewett, P
Raptis, I
Citation: A. Rosenbusch et al., Simulation of chemically amplified resist processes for 150 nm e-beam lithography, MICROEL ENG, 46(1-4), 1999, pp. 379-382
Citation: Cj. Delong et al., Molecular distinction of phosphatidylcholine synthesis between the CDP-choline pathway and phosphatidylethanolamine methylation pathway, J BIOL CHEM, 274(42), 1999, pp. 29683-29688
Citation: Z. Cui et al., Construction and characterization of a H19 epitope point mutant of MDV CVI988/Rispens strain, ACT VIROLOG, 43(2-3), 1999, pp. 169-173
Authors:
Tegou, E
Gogolides, E
Argitis, P
Raptis, I
Meneghini, G
Cui, Z
Citation: E. Tegou et al., Silylation and dry development of chemically amplified resists SAL601(1),AZPN114*(1), and epoxidised resist (EPR*(1)) for high resolution electron-beam lithography, JPN J A P 1, 37(12B), 1998, pp. 6873-6876
Authors:
Cui, Z
Gerardino, A
Gentili, M
DiFabrizio, E
Prewett, PD
Citation: Z. Cui et al., Comparative study of AZPN114 and SAL601 chemically amplified resists for electron beam nanolithography, J VAC SCI B, 16(6), 1998, pp. 3284-3288